Concepedia

M. Spengler

MS

Statistics

Publications

20

Citations

955

H-Index

15

Active since

1984

Affiliations

Bayer (Germany)(Current)

National University of Rosario

M. Spengler is an author at Bayer (Germany) specializing in medicine, diabetes mellitus, and pharmacotherapy.

Publications per year

1984–2014

20

Publications

20

Therapeutic Potentials of Acarbose as First-Line Drug in NIDDM Insufficiently Treated With Diet Alone

M Hanefeld, Sabine Fischer, Jan Schulze et al. · Diabetes Care · 1991 · 180 citations

, , +15

Efficacy of 24-Week Monotnerapy With Acarbose, Glibenclamide, or Placebo in NIDDM Patients: The Essen Study

Juergen Hoffmann, M. Spengler · Diabetes Care · 1994 · 147 citations

, , +17

Efficacy of 24-Week Monotherapy With Acarbose, Metformin, or Placebo in Dietary-Treated NIDDM Patients

Jürgen Hoffmann, M. Spengler · The American Journal of Medicine · 1997 · 146 citations

, , +6

Effect of Starch Malabsorption on Colonic Function and Metabolism in Humans

W Scheppach, Claudia Fabian, Frank Ahrens et al. · Gastroenterology · 1988 · 74 citations

, , +14

European study on dose-response relationship of acarbose as a first-line drug in non-insulin-dependent diabetes mellitus: efficacy and safety of low and high doses

Sabine Fischer, M Hanefeld, M. Spengler et al. · Acta Diabetologica · 1998 · 72 citations

, , +11

1–5 of 20